$21.73
0.42 (-1.90%)
Last updated: Apr 16, 2026 05:05
Fundamentals Overview
Sarepta Therapeutics, Inc. is near the low of its 52-week range with low valuation, trading relatively flat today.
Valuation low
Risk (Beta)
0.28 — lower vol
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
Sentiment improving (5 upgrades) · 3M vs Healthcare sector: +8.9%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: C+. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 2, Equal Weight: 3, Market Perform: 1, Neutral: 4, Outperform: 6, Overweight: 3, Sell: 7, Underperform: 4.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $-1,386.71; current price is $21.73. That’s a -6481.6% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | N/A |
| PEG (TTM) | N/A |
| P/B (TTM) | 2 |
| P/S (TTM) | 1.04 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 2.32 |
| Quick Ratio (TTM) | 1.48 |
| Cash Ratio (TTM) | 0.73 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | -32.45% |
| Gross margin (TTM) | 61.81% |
| Operating margin (TTM) | -31.83% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for SRPT.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Citigroup | maintain | Sell | Sell | 2026-03-26 |
| Needham | maintain | Underperform | Underperform | 2026-03-26 |
| Oppenheimer | maintain | Outperform | Outperform | 2026-03-19 |
| Mizuho | maintain | Outperform | Outperform | 2026-03-13 |
| Citigroup | maintain | Sell | Sell | 2026-03-10 |
| HC Wainwright & Co. | maintain | Sell | Sell | 2026-03-02 |
| Wells Fargo | maintain | Overweight | Overweight | 2026-02-27 |
| HC Wainwright & Co. | maintain | Sell | Sell | 2026-01-27 |
| Wedbush | maintain | Outperform | Outperform | 2026-01-23 |
| HC Wainwright & Co. | maintain | Sell | Sell | 2026-01-14 |
| Guggenheim | maintain | Buy | Buy | 2025-11-05 |
| Barclays | maintain | Equal Weight | Equal Weight | 2025-11-05 |
| Wells Fargo | maintain | Overweight | Overweight | 2025-11-05 |
| Mizuho | upgrade | Neutral | Outperform | 2025-11-05 |
| Baird | maintain | Neutral | Neutral | 2025-11-04 |
| Piper Sandler | maintain | Neutral | Neutral | 2025-10-30 |
| BMO Capital | upgrade | Market Perform | Outperform | 2025-09-22 |
| Guggenheim | maintain | Buy | Buy | 2025-09-15 |
| Leerink Partners | maintain | Market Perform | Market Perform | 2025-09-09 |
| HC Wainwright & Co. | maintain | Sell | Sell | 2025-08-25 |
| B of A Securities | maintain | Underperform | Underperform | 2025-08-21 |
| B of A Securities | maintain | Underperform | Underperform | 2025-08-20 |
| Deutsche Bank | maintain | Sell | Sell | 2025-08-15 |
| Goldman Sachs | maintain | Neutral | Neutral | 2025-08-07 |
| Wells Fargo | maintain | Overweight | Overweight | 2025-08-07 |
| Barclays | upgrade | Underweight | Equal Weight | 2025-07-30 |
| JP Morgan | upgrade | Underweight | Neutral | 2025-07-29 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2025-07-29 |
| Needham | maintain | Underperform | Underperform | 2025-07-29 |
| Oppenheimer | upgrade | Perform | Outperform | 2025-07-29 |